Helping a multinational pharmaceutical company expand its business to new markets A multinational pharmaceutical company wanted to accelerate growth beyond current strategic focus areas and mitigate a projected launch gap by acquiring promising drug candidates. Arthur D. Little was asked to help the client screen for advanced stage development compounds outside of the client’s current disease area footprint that might be attractive and innovative assets to target. White Space Selection Process Together with the client the scope of diseases to include was set and based on the scope the project was conducted in four phases using a funnel approach combining desk research and intensive interaction with Arthur D. Little’s expert network: Search for candidates through desk and database researc

Join for free to read